Tag: CDMO
BioCina and NovaCina team up to enhance biologics manufacturing capabilities
BioCina, a biologics Contract Development and Manufacturing Organisation (CDMO), has joined hands with NovaCina, a global fill-and-finish CDMO, to establish a strategic alliance aimed at offering integrated drug substance and drug product solutions for biologics developers.
BioCina secures funding to develop manufacturing tech for mRNA vaccine
Australian contract development and manufacturing organisation (CDMO) BioCina has received an AUD 5 million grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to develop enabling technologies for the manufacture of precision mRNA vaccines.
BioCina taps Mark Womack as CEO
Australian contract development and manufacturing organisation (CDMO) BioCina has appointed Mark Womack as the chief executive officer who will be responsible for the continued growth, commercial strategy and organisational culture of the company.
Samsung Biologics to add end-to-end mRNA vaccine manufacturing capability to its portfolio of services
Contract development and manufacturing organisation (CDMO) Samsung Biologics has unveiled plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility...
Featured Article
Embracing the future: Australian manufacturing trends in 2025
As the calendar turns to 2025, the Australian manufacturing sector stands at the cusp of transformation.
